The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens

Journal of Clinical Virology

Volumn 61, Issue 4, 2014, Pages 553-557

  Chen, Wen ^a   Jeronimo, Jose ^b   Zhao, Fang Hui ^a   Qiao, You Lin ^a   Valdez, Melissa ^b   Zhang, Xun ^a   Kang, Le Ni ^a   Bansil, Pooja ^b   Paul, Proma ^b   Bai, Ping ^a   Peck, Roger ^b   Li, Jing ^a   Chen, Feng ^a   Stoler, Mark H ^c   Castle, Philip E ^d  

^a CANCER HOSPITAL   (China)

^b PATH   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Global Coalition Against Cervical Cancer   (United States)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia (CIN); Human papillomavirus (HPV); Visual inspection after acetic acid (VIA)

Indexed keywords

ACETIC ACID; VIRUS DNA;

ADULT; AGED; ARTICLE; CHINA; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RURAL POPULATION;

ADULT; CHINA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RURAL POPULATION; SPECIMEN HANDLING;

EID: 84922744895     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.09.018     Document Type: Article

References (16)

1. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012, 62(May (3)):147-172.
2. New guidelines on screening and treatment for cervical cancer. South Africa: World Health Organization; 2013.
3. Zhao F.H., Jeronimo J., Qiao Y.L., Schweizer J., Chen W., Valdez M., et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) 2013, 6(September (9)):938-948.
4. Qiao Y.L., Jeronimo J., Zhao F.H., Schweizer J., Chen W., Valdez M., et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer 2014, 134(June (12)):2891-2901.
5. Kang L.N., Jeronimo J., Qiao Y.L., Zhao F.H., Chen W., Valdez M., et al. The optimal positive cutpoints of careHPV testing on clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China. J Clin Microbiol 2014, (March).
6. Qiao Y.L., Sellors J.W., Eder P.S., Bao Y.P., Lim J.M., Zhao F.H., et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008, 9(October (10)):929-936.
7. Labani S., Asthana S., Sodhani P., Gupta S., Bhambhani S., Pooja B., et al. CareHPV cervical cancer screening demonstration in a rural population of north India. Eur J Obstet Gynecol Reprod Biol 2014, 176(May):75-79. 10.1016/j.ejogrb.2014.03.006.
8. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008, 46(August (8)):604-2595.
9. Kleter B., Van Doorn L.J., Ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998, 153(December (6)):1731-1739.
10. Kleter B., Van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., Ter Schegget J., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999, 37(August (8)):2508-2517.
11. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El G.F., et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009, 10(April (4)):321-322.
12. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985, 4(January (1)):87-90.
13. Ngou J., Magooa M.P., Gilham C., Djigma F., Didelot M.N., Kelly H., et al. Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women. J Clin Microbiol 2013, 51(December (12)):4240-4242.
14. Lin C.Q., Chen F., Liu B., Zhang Y.Z., Cui X.L., Li A.M., et al. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China. J Virol Methods 2014, 202(June):73-78. 10.1016/j.jviromet.2014.03.002.
15. Gage J.C., Ajenifuja K.O., Wentzensen N., Adepiti A.C., Stoler M., Eder P.S., et al. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer 2012, 2(April):10.
16. Castle P.E., Schiffman M., Gravitt P.E., Kendall H., Fishman S., Dong H., et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002, 68(November (3)):417-423.